AIGH Capital Management LLC - Q3 2021 holdings

$476 Million is the total value of AIGH Capital Management LLC's 101 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 51.1% .

 Value Shares↓ Weighting
IWM SellISHARES TRput$109,375,000
-36.4%
500,000
-33.3%
23.00%
-25.7%
SIMO NewSILICON MOTION TECHNOLOGY COsponsored adr$29,117,0001,468,735
+100.0%
6.12%
EMKR  EMCORE CORP$25,209,000
-18.9%
3,370,1530.0%5.30%
-5.2%
PDFS BuyPDF SOLUTIONS INC$23,156,000
+41.5%
1,005,000
+11.7%
4.87%
+65.3%
PLAB BuyPHOTRONICS INC$18,683,000
+4.7%
1,370,734
+1.5%
3.93%
+22.3%
AVNW  AVIAT NETWORKS INC$18,227,000
+0.3%
554,6820.0%3.83%
+17.1%
BLIN NewBRIDGELINE DIGITAL INC$17,214,0001,259,644
+100.0%
3.62%
GRTX BuyGALERA THERAPEUTICS INC$16,496,000
-17.0%
2,036,495
+0.7%
3.47%
-3.1%
ADTN NewADTRAN INC$15,246,000812,656
+100.0%
3.21%
OIIM BuyO2MICRO INTERNATIONAL LIMITEspons adr$14,849,000
+12.7%
2,458,402
+34.5%
3.12%
+31.6%
ADMS BuyADAMAS PHARMACEUTICALS INC$12,696,000
-1.3%
2,585,743
+6.2%
2.67%
+15.3%
AVEO NewAVEO PHARMACEUTICALS INC$12,275,0001,986,176
+100.0%
2.58%
THTX SellTHERATECHNOLOGIES INC$11,962,000
-16.4%
3,023,036
-15.5%
2.52%
-2.3%
DZSI SellDZS INC$11,880,000
-47.0%
969,015
-10.3%
2.50%
-38.1%
PDSB SellPDS BIOTECHNOLOGY CORP$11,527,000
-38.7%
773,560
-48.4%
2.42%
-28.4%
XFOR BuyX4 PHARMACEUTICALS INC$8,805,000
-5.9%
1,664,540
+15.7%
1.85%
+10.0%
SCPH BuySCPHARMACEUTICALS INC$8,207,000
+109.1%
1,234,121
+92.2%
1.73%
+144.5%
PRTK BuyPARATEK PHARMACEUTICALS INC$7,821,000
+24.3%
1,609,398
+74.4%
1.64%
+45.2%
EDAP  EDAP TMS S Asponsored adr$7,709,000
-10.0%
1,208,2500.0%1.62%
+5.1%
PBYI SellPUMA BIOTECHNOLOGY INC$6,059,000
-40.8%
864,427
-22.4%
1.27%
-30.8%
AVYA  AVAYA HLDGS CORPcall$5,937,000
-26.4%
300,0000.0%1.25%
-14.0%
AMSC NewAMERICAN SUPERCONDUCTOR CORP$5,766,000395,487
+100.0%
1.21%
FKWL  FRANKLIN WIRELESS CORP$5,663,000
-23.5%
780,0000.0%1.19%
-10.7%
CYBE SellCYBEROPTICS CORP$4,147,000
-77.3%
116,566
-73.8%
0.87%
-73.5%
MYO NewMYOMO INC$4,139,000348,125
+100.0%
0.87%
RFIL  RF INDS LTD$4,035,000
+9.2%
495,0370.0%0.85%
+27.7%
WTT BuyWIRELESS TELECOM GROUP INC$3,866,000
-12.1%
1,867,639
+72.9%
0.81%
+2.7%
RNAZ NewTRANSCODE THERAPEUTICS INC$3,798,0001,270,500
+100.0%
0.80%
BKTI  BK TECHNOLOGIES CORPORATION$3,786,000
-10.3%
1,340,0000.0%0.80%
+4.7%
ALNA  ALLENA PHARMACEUTICALS$3,608,000
-30.6%
4,000,0000.0%0.76%
-18.9%
BWAY SellBRAINSWAY LTDsponsored ads$3,549,000
-54.2%
440,301
-42.1%
0.75%
-46.6%
HTGM  HTG MOLECULAR DIAGNOSTICS IN$3,494,000
-1.7%
612,0000.0%0.74%
+14.8%
PCSA  PROCESSA PHARMACEUTICALS INC$3,317,000
+4.6%
387,0970.0%0.70%
+22.2%
ASYS NewAMTECH SYS INC$3,121,000273,100
+100.0%
0.66%
DAIO  DATA I O CORP$2,731,000
-4.1%
418,3100.0%0.57%
+11.9%
MDNA  MEDICENNA THERAPEUTICS CORP$2,544,000
-8.1%
915,0000.0%0.54%
+7.4%
ACTG NewACACIA RESH CORP$2,464,000362,906
+100.0%
0.52%
CYTH NewCYCLO THERAPEUTICS INCcall$2,363,000350,000
+100.0%
0.50%
EVOK  EVOKE PHARMA INC$2,211,000
-5.1%
1,701,1850.0%0.46%
+10.7%
 IDEAL PWR INC$2,197,000
+19.7%
144,3470.0%0.46%
+40.0%
 ALIMERA SCIENCES INC$2,115,000
-53.6%
501,0250.0%0.44%
-45.8%
ANVS SellANNOVIS BIO INC$2,110,000
-80.5%
66,469
-47.4%
0.44%
-77.2%
NLSPW  NLS PHARMACEUTICS LTDcall$2,069,000
+137.3%
827,9210.0%0.44%
+177.1%
YTEN  YIELD10 BIOSCIENCE INC$2,049,000
-29.8%
342,0000.0%0.43%
-17.9%
ONDS SellONDAS HLDGS INC$1,898,000
-74.9%
207,070
-78.3%
0.40%
-70.7%
SCYX SellSCYNEXIS INC$1,819,000
-83.3%
343,126
-76.8%
0.38%
-80.4%
NUWE NewNUWELLIS INC$1,671,000760,000
+100.0%
0.35%
NewDERMATA THERAPEUTICS INCcall$786,000175,000
+100.0%
0.16%
NewDERMATA THERAPEUTICS INC$786,000175,000
+100.0%
0.16%
ARDS SellARIDIS PHARMACEUTICALS INC$554,000
-83.4%
150,591
-67.2%
0.12%
-80.5%
PETV NewPETVIVO HLDGS INCcall$270,000100,000
+100.0%
0.06%
PETV NewPETVIVO HLDGS INC$135,00050,000
+100.0%
0.03%
HSDT ExitHELIUS MED TECHNOLOGIES INC$0-101,214
-100.0%
-0.31%
CYTHW ExitCYCLO THERAPEUTICS INCcall$0-350,000
-100.0%
-0.32%
SLRX ExitSALARIUS PHARMACEUTICALS INC$0-1,800,000
-100.0%
-0.34%
HJLI ExitHANCOCK JAFFE LABORATORIES I$0-346,885
-100.0%
-0.43%
SNPX ExitSYNAPTOGENIX INC$0-316,945
-100.0%
-0.51%
ICLN ExitISHARES TRput$0-160,000
-100.0%
-0.68%
AVYA ExitAVAYA HLDGS CORP$0-360,000
-100.0%
-1.74%
ASPN ExitASPEN AEROGELS INC$0-655,819
-100.0%
-3.53%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AVIAT NETWORKS INC12Q3 20236.8%
SCPHARMACEUTICALS INC12Q3 20238.5%
THERATECHNOLOGIES INC11Q2 20232.9%
FRANKLIN WIRELESS CORP11Q3 20232.9%
IDEAL PWR INC11Q3 20232.5%
MEDICENNA THERAPEUTICS CORP11Q3 20231.1%
PARATEK PHARMACEUTICALS INC10Q1 20233.2%
LIGHTPATH TECHNOLOGIES INC10Q3 20233.0%
MYOMO INC10Q3 20231.3%
DZS INC9Q1 20237.5%

View AIGH Capital Management LLC's complete holdings history.

Latest significant ownerships (13-D/G)
AIGH Capital Management LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Bridgeline Digital, Inc.May 21, 2021627,4199.7%

View AIGH Capital Management LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-15
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-10
13F-HR2021-11-12

View AIGH Capital Management LLC's complete filings history.

Compare quarters

Export AIGH Capital Management LLC's holdings